Jeremy Steflik - Concepedia

Author

Jeremy Steflik

Pfizer (United States)ORCID

Also Known As

Jeremy S. Steflik, Jeremy Steflik

Publications

957

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Pfizer (Ireland)Pfizer (United Kingdom)University of Manchester University of Graz

About

Jeremy Steflik is an author at Pfizer (United States) specializing in natural sciences, biochemistry, and biomolecular engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	8	8	455
2	Biochemistry	8	8	455
3	Engineering	5	5	308
4	Medicine	1	1	26
5	Allergy	1	1	26

Jeremy Steflik

Publications

947

Citations

H-Index

Page 1

	Year	Citations
Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion Fletcher A. White, Jihu Sun, Stephen M. Waters, Proceedings of the National Academy of Sciences	2005	368
Biocatalytic reductive amination from discovery to commercial manufacturing applied to abrocitinib JAK1 inhibitor Rajesh Kumar, Michael J. Karmilowicz, Dylan Burke, Nature Catalysis Medicinal ChemistryEngineeringCommercial ManufacturingBiochemistryJak1 Inhibitor	2021	129
Identification of Novel Bacterial Members of the Imine Reductase Enzyme Family that Perform Reductive Amination Scott P. France, Roger M. Howard, Jeremy Steflik, ChemCatChem BiochemistryNatural SciencesBiocatalysisNovel Bacterial MembersImine Formation	2017	104
Biocatalytic Routes to Enantiomerically Enriched Dibenz[<i>c</i>,<i>e</i>]azepines Scott P. France, Godwin A. Aleku, Mahima Sharma, Angewandte Chemie International Edition	2017	91
Chemoenzymatic Asymmetric Synthesis of Pregabalin Precursors via Asymmetric Bioreduction of β-Cyanoacrylate Esters Using Ene-Reductases Christoph K. Winkler, Dorina Clay, Simon B. Davies, The Journal of Organic Chemistry EngineeringOrganic ChemistryPregabalin PrecursorsGaba AnaloguesDiversity Oriented Synthesis	2013	89
Evaluation of Several Routes to Advanced Pregabalin Intermediates: Synthesis and Enantioselective Enzymatic Reduction Using Ene-Reductases Sébastien Debarge, Paul McDaid, P.M. O'Neill, Organic Process Research & Development Bioorganic ChemistryAdvanced PregabalinEngineeringMolecular BiologyOrganic Chemistry	2013	45
Nitrile as Activating Group in the Asymmetric Bioreduction of β‐Cyanoacrylic Acids Catalyzed by Ene‐Reductases Christoph K. Winkler, Dorina Clay, Nikolaus G. Turrini, Advanced Synthesis & Catalysis	2014	33
Application of Biocatalytic Reductive Amination for the Synthesis of a Key Intermediate to a CDK 2/4/6 Inhibitor Shengquan Duan, Daniel W. Widlicka, Michael P. Burns, Organic Process Research & Development Key IntermediateEngineeringStreamlined SynthesisCdk 2/4/6Organic Chemistry	2021	32
Molecular Characterization of the Gerbil C5a Receptor and Identification of a Transmembrane Domain V Amino Acid That Is Crucial for Small Molecule Antagonist Interaction Stephen M. Waters, Robbin Brodbeck, Jeremy Steflik, Journal of Biological Chemistry ImmunologyImmunologic MechanismInflammationMolecular PharmacologyMolecular Characterization	2005	26
Engineering of a Reductive Aminase to Enable the Synthesis of a Key Intermediate to a CDK 2/4/6 Inhibitor Jeremy Steflik, Amelia K. Gilio, Michael P. Burns, ACS Catalysis Reductive Amination ReactionMedicinal ChemistryReductive AminaseKey IntermediateBiochemistry	2023	17

Page 1